HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Removal of Procalcitonin and Selected Cytokines during Continuous Veno-Venous Hemodialysis Using High Cutoff Hemofilters in Patients with Sepsis and Acute Kidney Injury.

AbstractINTRODUCTION:
The purpose of this study was to evaluate the impact of continuous veno-venous hemodialysis (CVVHD) using high cutoff (HCO) hemofilters on the removal of procalcitonin (PCT), and other inflammatory markers in the treatment of patients during septic shock with acute kidney injury (AKI).
MATERIALS AND METHODS:
Thirty-six patients with septic shock and AKI were included in the study. Before and after the 24-h HCO-CVVHD, PCT, native C-reactive protein (CRP) and cytokines (interleukin-1β, interleukin-6, interleukin-12, interleukin-17, tumor necrosis factor-α) in serum and effluent were assessed.
RESULTS:
After the HCO-CVVHD serum concentrations of PCT, CRP and selected cytokines were significantly lower. The decrease in PCT was bigger than in CRP (p = 0.007). The change in PCT concentration was significantly influenced by PCT and IL-17 clearances (R2 = 0.525; p < 0.001).
CONCLUSION:
In contrast to the native CRP, monitoring of PCT during HCO-CVVHD is less useful because it reflects the clearance of this marker and anti-inflammatory effectiveness of the method.
AuthorsGrzegorz Kade, Sławomir Literacki, Agnieszka Rzeszotarska, Stanisław Niemczyk, Arkadiusz Lubas
JournalBlood purification (Blood Purif) Vol. 46 Issue 2 Pg. 153-159 ( 2018) ISSN: 1421-9735 [Electronic] Switzerland
PMID29705804 (Publication Type: Journal Article)
CopyrightThe Author(s). Published by S. Karger AG, Basel.
Chemical References
  • Cytokines
  • Procalcitonin
  • C-Reactive Protein
Topics
  • Acute Kidney Injury (complications)
  • Aged
  • C-Reactive Protein (analysis)
  • Cytokines (isolation & purification)
  • Female
  • Hemofiltration (methods)
  • Humans
  • Male
  • Middle Aged
  • Procalcitonin (analysis, isolation & purification)
  • Renal Dialysis (instrumentation, methods)
  • Sepsis (complications)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: